Vorträge, ausgesuchte Veröffentlichungen und Bilder
Sie dürfen nach nur nach Rücksprache bzw. auf Bitte von mir genutzt werden.
W. Wodarg
Der Beitrag darf unter Nennung des Autoren unter CC BY-NC-ND 4.0 Lizenz publiziert werden.
I recommend thorough reconsideration of the use of chloroquine and intravenous high-dose vitamin-C for treatment or prophylaxis of Covid-19!
Dr. Wolfgang Wodarg, 14.4.2020
A young doctor in an intensive care unit (ICU) in New York made an important observation.
He experienced several patients, that did not show any typical symptoms of pneumonia but nevertheless they were extremely breathless (dyspnoeic) and cyanotic (blue skin). "They were no Covid-19 patients, they looked like passengers of an airplane at high altitude loosing pressure."
Ventilators, intensive care and drug trials for SARS-CoV-19 infected persons are in. Not only multimorbid elderly people with a positive SARS-CoV-2 test are at high
risk of dangerous side effects. It may very well be that the virus is less dangerous than some hasty treatments. In addition, there are now more than 500 clinical trials related to Covid-19 done
under time pressure, which easily leads to increased risks for those being treated. The following long-known fact is not taken into account in almost one third of the 91 registered studies
with hydroxychloroquine:
It is known that e.g. chloroquine and high intravenous doses of vitamin C damage the function of the erythrocytes in a glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency/favism).
This is the most common enzyme deficiency worldwide. The defect is hereditary and men are much more at risk. Most carriers of this genetic defect are found in countries where malaria is or was
endemic. Therefore people with ancestors from such regions are also at risk of suffering from haemolysis, oxygen deficiency and dyspnoea if they receive for example chloroquine derivatives or
high doses of vitamin C intravenously. It is likely that this effect is more common in countries with a higher prevalence of G6PD deficiency/favism and in regions with many migrants from these
countries. Does this factor perhaps play a role in Mediterranean countries, China or New York? As in Hamburg, all Covid-19 deaths should be thoroughly investigated so that risks and wrong
treatments can be quickly identified and mitigated.
